Literature DB >> 32197730

Measuring Quality-Adjusted Life-Years When Health Fluctuates.

Sabina Sanghera1, Joanna Coast2.   

Abstract

Recurrent fluctuations in health states can occur as a result of long-term conditions with episodic symptoms or through side effects of cycles of treatment. Fluctuations and associated duration of symptoms can be predictable (eg, side effects of chemotherapy treatment) or unpredictable (eg, relapse in multiple sclerosis). Such recurrent fluctuations in health states can have an important impact on a person's health-related quality of life. When symptoms vary by time of day, day of the week, or during the month, it is challenging to obtain reliable health-related quality of life estimates for use in assessing cost-effectiveness of interventions. The adequacy of the quality of life estimate will be affected by (1) the standard recall period associated with the chosen measure (eg, "health today" EQ-5D, "past 4 weeks" for SF-36/SF-6D) and the way that respondents understand and make judgments about these recall periods, (2) the chosen time points for assessing health-related quality of life in relation to the fluctuations in health, and (3) the assumptions used to interpolate between measurement time points and thus calculate the quality-adjusted life-years. These issues have not received sufficient methodological attention and instead remain poorly accounted for in economic analyses. There is potential for these issues to considerably distort treatment decisions away from the optimal allocation. This article brings together evidence from health economics, psychology, and behavioral economics to explore these challenges in depth; presents the solutions that have been applied to date; and details a methodological research agenda for measuring quality-adjusted life-years in recurrent fluctuating health states.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  QALYs; economic evaluation; fluctuating health; quality of life; recall; timing of assessment

Mesh:

Year:  2019        PMID: 32197730     DOI: 10.1016/j.jval.2019.09.2753

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  6 in total

1.  Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy.

Authors:  India Flint; Jasmina Medjedovic; Ewa Drogon O'Flaherty; Elena Alvarez-Baron; Karthinathan Thangavelu; Natasa Savic; Aurelie Meunier; Louise Longworth
Journal:  Eur J Health Econ       Date:  2022-10-19

2.  Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.

Authors:  M Cochrane; E Mitchell; W Hollingworth; E Crawley; D Trépel
Journal:  Appl Health Econ Health Policy       Date:  2021-03-01       Impact factor: 3.686

3.  Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses.

Authors:  Sabina Sanghera; Axel Walther; Tim J Peters; Joanna Coast
Journal:  Patient       Date:  2021-12-02       Impact factor: 3.481

4.  Response process validity of three patient reported outcome measures for people requiring kidney care: a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O.

Authors:  Paul Mark Mitchell; Fergus John Caskey; Jemima Scott; Sabina Sanghera; Joanna Coast
Journal:  BMJ Open       Date:  2020-05-15       Impact factor: 2.692

5.  The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems.

Authors:  F C W van Krugten; J J V Busschbach; M M Versteegh; L Hakkaart-van Roijen; W B F Brouwer
Journal:  Qual Life Res       Date:  2021-07-09       Impact factor: 4.147

6.  Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms.

Authors:  Koonal K Shah; Bryan Bennett; Andrew Lenny; Louise Longworth; John E Brazier; Mark Oppe; A Simon Pickard; James W Shaw
Journal:  Eur J Health Econ       Date:  2021-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.